Request a briefing

FDA-approved agent·Novel second medical use·Post-trauma intervention·Fear-memory consolidation modulation·Critical window deployment·PTSD prevention·Medical device + pharma convergence·IP protected·505(b)(2) pathway·FDA-approved agent·Novel second medical use·Post-trauma intervention·Fear-memory consolidation modulation·Critical window deployment·PTSD prevention·Medical device + pharma convergence·IP protected·505(b)(2) pathway·

Contact

Get in touch.

Tell us who you are and what you're looking for. Investor materials, the full scientific package and direct lines to the founding team are released on request.

Send an inquiry

Start the conversation.

Name Organization

Email Phone

I'm reaching out about Message

We reply within two business days.

Qualified investors only

Direct line to the CEO

We keep the founding team's personal details off the open web. Confirm you're an investor or clinical partner and they'll be shown here.

Make trauma a memory,
not a disorder.

We need to act now.

Stealth · Detailed materials shared under NDA

Get in touch.

Start the conversation.

Inquiry sent.

Direct line to the CEO

Make trauma a memory,not a disorder.

Make trauma a memory,
not a disorder.